MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
In modern acute care, emergency medicine, and oncology wards, conventional open IV cannulas present persistent clinical challenges: blood leakage during needle stylet extraction, heightened vulnerability to catheter-related bloodstream infections (CRBSIs), mechanical phlebitis due to direct hub manipulation, and accidental needle-stick injuries. The Closed Loop IV Catheter System represents an evolutionary leap in vascular access technology—integrating an indwelling catheter, blood control septum, pre-attached extension line, and needleless access valve into a single pre-assembled, sterile, closed fluid pathway.
A true Closed Loop IV Catheter System isolates the blood path from external atmospheric and microbial exposure from the exact moment of venipuncture through the entire dwell duration. Unlike traditional open system IV catheters that rely on manual vein compression to prevent blood flashback leakage during stylet removal, integrated closed systems feature a self-sealing internal blood control valve. As the needle is withdrawn, the valve automatically shuts, completely eliminating blood spillage onto clinician gloves, bed linens, or surrounding equipment.
Furthermore, because the extension tubing is permanently attached to the catheter hub during factory clean-room assembly, clinical operators never perform direct hub attachment at the patient's bedside. All flushes, blood sampling procedures, and infusion set connections occur at the remote end of the extension line, dramatically reducing mechanical manipulation at the insertion site. Clinical trials show this architecture lowers mechanical phlebitis by up to 60% and decreases catheter failure rates, enabling extended dwell times up to 96 hours in full alignment with INS (Infusion Nurses Society) recommendations.
Engineered for maximum bio-compatibility, low insertion force, and absolute fluid control. Available in comprehensive gauge ranges (16G through 26G) with customizable extension tubing configurations for global healthcare procurement.
Integrated closed system with single-line extension tube, passive needle safety housing, and blood control septum. Minimizes dead space and prevents blood exposure during vascular entry.
Designed for ICU, surgical, and oncology patients requiring concurrent medication delivery. Features a dual-extension Y-branch with colour-coded clamp locks and dual needle-free valves.
Ultra-fine 24G and 26G catheter configurations with micro-bore extension tubing, engineered specifically for fragile pediatric and neonatal veins requiring minimal insertion force.
Below is the standardized engineering specification matrix utilized by healthcare procurement officers, hospital biomedical engineers, and tender committees when evaluating Lars Medicare's OEM Closed Loop IV Catheter Systems:
| Gauge Size | Color Code | Catheter O.D. x Length | Gravity Flow Rate (mL/min) | Extension Line Length | Priming Vol. (mL) | Recommended Clinical Target |
|---|---|---|---|---|---|---|
| 16G | Grey | 1.7 mm x 45 mm | 180 - 200 mL/min | 100 mm / Custom | < 0.35 mL | Trauma, Surgery, Rapid Blood Transfusion |
| 18G | Green | 1.3 mm x 32/45 mm | 90 - 105 mL/min | 100 mm / Custom | < 0.30 mL | Major Surgery, Viscous Parenteral Nutrition |
| 20G | Pink | 1.1 mm x 32 mm | 60 - 65 mL/min | 100 mm / Custom | < 0.25 mL | Routine Inpatient IV Infusions, Antibiotics |
| 22G | Blue | 0.9 mm x 25 mm | 33 - 38 mL/min | 100 mm / Custom | < 0.20 mL | Elderly Patients, Fragile Veins, Oncology |
| 24G | Yellow | 0.7 mm x 19 mm | 20 - 23 mL/min | 80 mm / Micro-bore | < 0.15 mL | Pediatric, Neonatal Critical Care |
| 26G | Violet | 0.6 mm x 19 mm | 13 - 15 mL/min | 80 mm / Micro-bore | < 0.12 mL | Extreme Neonatal Access, Micro-Infusion |
Global medical disposable procurement is undergoing a fundamental structural transition. Driven by international infection control standards, occupational health mandates, and economic total-cost-of-care analyses, healthcare authorities are phasing out legacy open cannulas in favor of integrated closed loop architectures.
National health regulators across the EU (under EU Directive 2010/32/EU), the US OSHA Bloodborne Pathogens Standard, and expanding health directives in Latin America and the Middle East now strictly penalize non-safety vascular devices. Future tenders explicitly demand integrated passive safety shielding combined with fluid-containment septa. Hospitals adopting Closed Loop IV Catheter Systems achieve near-zero rates of accidental blood exposure during insertion, directly mitigating hospital liability and occupational hazards.
Procurement trends show a massive displacement of Fluorinated Ethylene Propylene (FEP) catheters by Thermoplastic Polyurethane (PUR). PUR catheters remain rigid during initial needle insertion to facilitate smooth skin penetration but soften rapidly inside the vein under body temperature (37°C). This thermal softening capability reduces mechanical vein irritation, lowers chemical phlebitis rates, and prevents catheter kinking, allowing indwelling dwell times to safely extend up to 96 hours without clinical compromise.
In accordance with REACH regulations and EU MDR Annex I requirements, major hospital networks are prohibiting DEHP (Di(2-ethylhexyl)phthalate) plasticizers in intravenous tubing—especially for pediatric, neonatal, and long-term chemotherapy applications. Lars Medicare's Closed Loop IV Catheter Systems utilize 100% DEHP-free and latex-free medical-grade polyurethane and specialized TOTM (Trioctyl Trimellitate) or DINCH plasticized PVC extension lines, establishing the gold standard for patient safety.
While an integrated Closed Loop IV Catheter System carries a higher initial unit procurement cost than a standalone open cannula, health economic assessments prove a significant net savings per patient day. By eliminating the separate purchase of extension sets, needle-free valves, and gauze sponges for blood cleanup—and by reducing catheter failure restart rates by over 40%—hospitals achieve substantial labor, material, and infection-treatment savings across acute care wards.
Founded in 2005, Lars Medicare Private Limited operates a world-class, fully integrated manufacturing ecosystem in Sonepat, Haryana (India), supported by global distribution management in New Delhi and North American logistics headquarters in Milton, Ontario (Canada). Our facility operates under rigorous ISO 13485:2016 quality management systems and holds full CE certifications under European Medical Device regulations.
Direct governance by industry experts ensures absolute fidelity to technical specs, contractual delivery timelines, and global regulatory compliance.
20+ years of pioneering medical disposable engineering and manufacturing excellence. Directs quality systems, tooling innovation, and global regulatory compliance.
Spearheads international distributor relations, OEM product line expansion, and public health tender execution across European, Latin American, and Asian regions.
Manages North American sales operations, supply chain logistics, and distributor technical support from our Milton, Ontario hub.
Detailed technical answers to common queries submitted by global procurement officers, biomedical engineers, hospital buyers, and medical device distributors regarding Closed Loop IV Catheter Systems.
A Closed Loop IV Catheter System incorporates an internal blood-control valve (septum) housed directly within the catheter hub, coupled with a factory-sealed, pre-attached extension tube. During initial venipuncture, as the sharp metal needle stylet is withdrawn from the plastic catheter sheath, the internal elastomeric septum automatically closes. This shut-off action occurs instantaneously before the needle is completely removed, completely blocking the outflow of blood from the vein.
Unlike traditional open IV cannulas—which rely on clinicians to manually compress the vein with one hand while trying to attach an extension set or cap with the other—the closed system maintains a 100% fluid-tight barrier. This eliminates blood spillage onto gloves, patient skin, bedding, or floor surfaces, protecting healthcare workers from bloodborne pathogens (such as Hepatitis B, Hepatitis C, and HIV) and dramatically simplifying clinical infection control.
Importing advanced vascular access devices into regulated markets requires a rigorous Technical Documentation Dossier. Lars Medicare provides global importers with complete regulatory submission binders, including:
Yes. Lars Medicare specializes in full-scope OEM and private-label manufacturing. Because we maintain our own precision tool room, micro-injection molding equipment, and automated extrusion lines in Sonepat, we offer comprehensive customization parameters:
For standard catalogue items under the Lars Medicare brand or neutral unbranded packaging, initial trial orders can begin at one mixed pallet. For custom OEM private-label contracts, the standard Minimum Order Quantity (MOQ) is 20,000 units per gauge size to optimize cleanroom high-speed assembly and custom printing runs.
Lead Times: Repeat commercial orders for established private-label SKUs typically dispatch from our Sonepat plant within 3 to 4 weeks. First-time OEM programs require 5 to 7 weeks to allow complete artwork proofing, custom plate creation, pilot cleanroom assembly, EO sterilisation validation, and final quality release inspection.
Mechanical phlebitis occurs when movements of the indwelling catheter irritate the delicate endothelial lining of the vein. In traditional open IV cannula setups, every time a nurse attaches a syringe for flushing, connects an infusion line, or changes a valve, physical push-and-pull torque is transmitted directly to the catheter hub resting inside the vein.
A Closed Loop IV Catheter System isolates the catheter hub from direct physical contact. Because the extension line is permanently fused to the catheter during factory manufacturing, all clinical manipulations (syringe connections, line changes, blood draws) occur at the remote end of the extension line, far away from the venipuncture site. Clinical data indicates this architecture reduces catheter micro-motion within the vessel wall by over 70%, lowering mechanical phlebitis rates to under 2% and virtually eliminating accidental catheter dislodgement.
Lars Medicare enforces a multi-tier quality assurance protocol across 100% of manufactured closed catheter units:
Lars Medicare Closed Loop IV Catheter Systems carry a certified 5-Year Shelf Life when stored in their original unopened blister packaging. Packaging consists of high-barrier medical grade paper-film pouches that maintain sterile seal integrity against moisture, dust, and environmental contaminants.
Storage Recommendations: Consignments should be stored in a clean, cool, dry medical warehouse at temperatures between 5°C and 35°C, away from direct sunlight, UV sources, radiation, and corrosive chemical fumes. Cartons should be stacked on pallets off the ground in accordance with first-expiry-first-out (FEFO) inventory management practices.
16–19 November 2026 · Hall 6, Stall No. F37. Inspect our full range of Closed Loop IV Catheter Systems, safety blood control cannulas, and DEHP-free IV infusion lines. Meet our engineering and international export leadership team to structure your market-exclusive OEM distribution contracts.
Whether you are preparing a national public healthcare tender, expanding your hospital supply catalogue, or seeking a certified OEM manufacturer for private-label Closed Loop IV Catheter Systems, Lars Medicare provides rapid technical support, regulatory binders, and competitive factory-direct pricing.
Submit your gauge mix, estimated annual volume, and destination country to receive a comprehensive technical proposal within 24 hours.
In-depth technical articles written by our engineering, QA, and global regulatory compliance teams.
Technical compliance, CE MDR certification, and total-cost-of-care evaluation criteria for EU public hospital tenders.
Join our technical team in Düsseldorf to review automated blood control mechanisms and passive needle safety clips.
How distributor partners in LATAM, Africa, and Southeast Asia successfully execute conversion programs from open cannulas.